PMID- 25298750 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20141009 LR - 20211021 IS - 1475-2867 (Print) IS - 1475-2867 (Electronic) IS - 1475-2867 (Linking) VI - 14 IP - 1 DP - 2014 TI - Human umbilical cord mesenchymal stem cells promote carcinoma growth and lymph node metastasis when co-injected with esophageal carcinoma cells in nude mice. PG - 93 LID - 10.1186/s12935-014-0093-9 [doi] LID - 93 AB - BACKGROUND: Human umbilical cord blood derived-mesenchymal stem cells (hUCMSCs) offer an attractive alternative to bone marrow-derived MSCs (BMMSCs) for cell-based therapy as it is a less invasive source of biological material. However, limited studies have been conducted with hUCMSCs as compared to BMMSCs. The present study was conducted to evaluate the effects of hUCMSCs in esophageal carcinoma (EC). METHODS: hUCMSCs together with EC cells were transplanted subcutaneously into BALB/c nude mice to observe the effects of hUCMSCs on tumor establishment. hUCMSCs injected through the caudal vein to the mice with pre-established EC to observe the effects of hUCMSCs on tumor outgrowth. In order to elucidate the underlying mechanisms, we also performed in vitro experiments including directly co-culture, transwell assay, proliferation assay and western blotting analysis. RESULTS: hUCMSCs promoted EC formation in nude mice. In the in vivo model of pre-established EC, intravenously injected hUCMSCs potently promoted tumor growth. When in vitro co-cultured with hUCMSCs, EC cells proliferation increased. After co-cultured with hUCMSCs through transwell system, EC cells showed increased proliferation. Through transwell assay, we also observed that EC cells recruited MSCs, and MSCs promoted EC cells migration and invasion. Western blotting data showed that the expressions of proliferation related proteins Bcl-2, survivin and metastasis related proteins MMP-2 and MMP-9 were up-regulated in the EC cells transwell co-cultured with hUCMSCs. CONCLUSIONS: Our results indicated that hUCMSCs could favor tumor growth in vivo and in vitro. Thus, the exploitation of hUCMSCs in new therapeutic strategies should be cautious under the malignant conditions. FAU - Yang, Xiaoya AU - Yang X AD - Blood Transfusion Department, The Bethune International Peace Hospital, Shijiazhuang, 050082 Hebei P R. China. FAU - Li, Zhu AU - Li Z AD - Blood Transfusion Department, The Bethune International Peace Hospital, Shijiazhuang, 050082 Hebei P R. China. FAU - Ma, Yintu AU - Ma Y AD - Blood Transfusion Department, The Bethune International Peace Hospital, Shijiazhuang, 050082 Hebei P R. China. FAU - Gao, Jun AU - Gao J AD - Blood Transfusion Department, The Bethune International Peace Hospital, Shijiazhuang, 050082 Hebei P R. China. FAU - Liu, Surui AU - Liu S AD - Blood Transfusion Department, The Bethune International Peace Hospital, Shijiazhuang, 050082 Hebei P R. China. FAU - Gao, Yuhua AU - Gao Y AD - Blood Transfusion Department, The Bethune International Peace Hospital, Shijiazhuang, 050082 Hebei P R. China. FAU - Wang, Gengyin AU - Wang G AD - Blood Transfusion Department, The Bethune International Peace Hospital, Shijiazhuang, 050082 Hebei P R. China. LA - eng PT - Journal Article DEP - 20140924 PL - England TA - Cancer Cell Int JT - Cancer cell international JID - 101139795 PMC - PMC4189553 OTO - NOTNLM OT - Esophageal carcinoma OT - Mesenchymal stem cells OT - Metastasis OT - Tumor growth OT - Umbilical cord EDAT- 2014/10/10 06:00 MHDA- 2014/10/10 06:01 PMCR- 2014/09/24 CRDT- 2014/10/10 06:00 PHST- 2014/01/23 00:00 [received] PHST- 2014/09/05 00:00 [accepted] PHST- 2014/10/10 06:00 [entrez] PHST- 2014/10/10 06:00 [pubmed] PHST- 2014/10/10 06:01 [medline] PHST- 2014/09/24 00:00 [pmc-release] AID - 93 [pii] AID - 10.1186/s12935-014-0093-9 [doi] PST - epublish SO - Cancer Cell Int. 2014 Sep 24;14(1):93. doi: 10.1186/s12935-014-0093-9. eCollection 2014.